Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Outlook on the Global Monoclonal Antibodies Market (2020 to 2024) - by Source, Application, End-users & Region - ResearchAndMarkets.com


The "Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024.

The factors such as, increasing incidences of new cancer cases, escalating sales of biologics, growth in geriatric population, increasing pharmaceutical R&D spending, rise in prevalence of diabetes and upsurge in healthcare expenditure would drive the growth of the market. However, the market growth would be challenged by the high cost involved in the development of the therapeutic monoclonal antibodies, threats associated with drugs counterfeiting and legal regulations. A few notable trends include accelerating growth rates of infectious diseases, growth in the pharmaceutical & biotechnology M&A, development of new monoclonal antibodies and emergence of stereo-specific monoclonal antibodies.

The global monoclonal antibodies market is very lucrative as there is wide scope for its application for various indications. The rising prevalence of cancer is leading to the demand for humanized monoclonal antibodies as such class of drugs can target cancer cell at rapid speed as well as reduce their multiplication. In addition, monoclonal antibodies have found application in research and development of various novel drugs as well as therapies, which is providing a great opportunity for its market growth across the world.

The fastest-growing regional market is North America due to the presence of biopharmaceutical key players and the well-established healthcare infrastructure. It is followed by Europe and the Asia Pacific, which also hold a considerable share in the global market, owing to the increased application of monoclonal antibodies. Further, the rising number of coronavirus cases is augmenting the need for precise therapeutic options, which is leading to the development of mono-specific and thereby would help the monoclonal antibodies market to grow considerably in the coming year.

Scope of the report:

Market Dynamics

Growth Drivers

Key Trends and Developments

Challenges

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/hmz2hq


These press releases may also interest you

at 13:30
The "Data Center Rack Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The data center rack market by revenue is expected to grow at a CAGR of close to 4% during the period 2019-2025.The...

at 13:30
Novo Seeds, the early stage investment and company creation team of Novo Holdings, today announced that its portfolio company Galecto Inc. (Galecto), a privately-held biotechnology company focused on the development of novel treatments for fibrosis...

at 13:30
Vuzix® Corporation , ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Clorox has successfully deployed Vuzix M400 Smart Glasses equipped with Atheer software to...

at 13:27
MyScript begins a new chapter with Nebo 2.7 and its freeform page, which empowers users to take their note-taking in creative new directions. Over 5 million people already use the award-winning Nebo. The app employs advanced AI to provide a...

at 13:11
Carbon nanotubes (CNTs) have been known for many decades, but the moment of significant commercial growth is just approaching. Through expansions, partnerships, acquisitions, and greater market adoption there are clear indicators that now is the time...

at 13:09
AMDT Holdings, Inc. develops disruptive products to address existing and emerging needs in the extremity market. The flagship products for AMDT Holdings are the patented SixFix® Circular Fixation System, the patented SixFix Deformity Analysis and...



News published on 13 august 2020 at 12:00 and distributed by: